17th Eemeli Workshop. Wednesday 13th August 2014 VTT, Micronova, Tietotie 3, Espoo. Juhani Luotola, Orion Diagnostica Oy

Size: px
Start display at page:

Download "17th Eemeli Workshop. Wednesday 13th August 2014 VTT, Micronova, Tietotie 3, Espoo. Juhani Luotola, Orion Diagnostica Oy"

Transcription

1 17th Eemeli Workshop Wednesday 13th August 2014 VTT, Micronova, Tietotie 3, Espoo Juhani Luotola, Orion Diagnostica Oy Juhani Luotola / R&D 13/12/2014 1

2 2

3 Personalized Diagnostics and Care Personalized health care is a global trend, which creates plenty of new business opportunities An individualized health care is needed, so that eg. the most expensive treatments can be targeted to those who really will benefit from these treatments. The public sector has the main responsibility for the reforms, but this goal is realized only in broad cooperation with all sectors. This program allows the Finnish actors to be involved at the forefront in developing new operating models. Finnish health care infrastructure provides a good framework for the implementation of the program and for new ways of acting. The program is an excellent example of cooperation between different sectors of the society! 3

4 Personalized Diagnostics and Care The overall objective of the Personalized Diagnostics and Care program is to partially change health care priorities from waiting of symptoms towards early prevention of disease using personalized diagnostics and treatment. The program will also create new health care technologies and practices. Performing the research needed in the program would be completely impossible without the cooperation with major actors in the health sector. Extensive co-operation with all parties enables utilization of the genome information in clinical healthcare by an effective and responsible manner, taking also into account the sociological and socioeconomic aspects. The Academy of Finland program Personalised Health From genes to society is also complementing the whole. 4

5 For the first time in Finnish health and well-being area, "Personalized Diagnostics and Care" program will enable stakeholders in public and private health care, occupational health, multidisciplinary research and industry to build together new approaches for personalized diagnostics and care. GET IT DONE. Personalized Diagnostics and Care The overall objective of the program is to enhance the use of personalized medicine, especially personalized diagnostics and treatments. The program focuses on the efficient utilization of personal health records, patient records and genomic information including new technologies in point-of-care testing. The ICT solutions to be developed, including genetic and other laboratory data, support the effective use of patient data both in the prevention and care of diseases. - GET IT DONE. 5

6 The Consortium The consortium consists of 17 parties, 12 companies and 5 research organisations with 16 research groups in total. The participating companies: Labsystems Diagnostics Oy (earlier Ani Labsystems ALS), ArcDia International Oy Ltd, Carea Kymenlaakso Social and Health Services, Duodecim Medical Publications Ltd, Pharmaceutical Information Centre (LTK), HUS - The Hospital District of Helsinki and Uusimaa, Oy Medix Biochemica Ab, Mehiläinen Oy, Orion Diagnostica Oy (OD), Orion Pharma (OP), The Finnish Red Cross Blood Service (SPR) and United Medix Laboratories Ltd (YML). The research organisations: Aalto University, The Research Institute of the Finnish Economy - Etla, University of Helsinki (UH), University of Tampere (UTA), VTT Technical Research Centre of Finland. 6

7 Work Packages of Personalized Diagnostics and Care Program WP501 WP502 WP503 WP504 Infections, inflammation and enabling technologies for diagnostics and care Extracellular vesicles in health and disease Healthcare processes and electronic evidencebased decision support systems Genomics in chronic inflammation in Finland and Canada (CINFICA) Duration: Volume: 30 m Partners: 17 7

8 Responsibilities of work packages and budgeting Research Coordinator of the program since Aug 4 th 2014: Dr. Pirjo Wacklin, PhD, SalWe Oy 8

9 Infections, inflammation and enabling technologies for diagnostics and care (WP501) WP managers: Minna Mäki, Orion Diagnostica ja Harri Siitari, VTT WP501.1: Chronic inflammation and acute microbial infections in the gastrointestinal (GI) tract WP501.1A: Chronic inflammation in the GI tract WP501.1B: Acute microbial infections in the GI tract WP501.2: Diagnostics of acute respiratory tract infections WP501.2A: Novel diagnostic targets for group G and C streptocci WP501.2B: Novel diagnostic targets for viral respiratory tract infections WP501.3 Infections and inflammatory conditions during pregnancy and delivery WP501.3A: Novel diagnostic targets for early intra-amniotic infection WP501.3B: Novel diagnostic targets for Group B Streptococcus (GBS) and the GBS carrier state of the mother WP501.4: Integrated methods for sample preparation WP501.5A: One-step multiplex assay platform WP501.5B: Mobile POC technologies 9

10 Extracellular vesicles in health and disease (WP502) WP managers: Saara Laitinen, SPR Veripalvelu ja Elina Serkkola, Orion Pharma WP502.1: Extracellular vesicles in healthy donors - Blood based biomarkers WP502.2: Extracellular vesicles as a source of biomarkers for prostate cancer 10

11 Healthcare processes and electronic evidence-based decision support systems (WP 503) WP managers: Pasi Pöllänen, CAREA and Kimmo Pitkänen, HY FIMM WP503-1: Integrating Genetic Information and Electronic Clinical Decision Support WP503-2: Personalized medicine decision support system WP503-3: Immunogenetic profiling based on genome data WP503-4: Automatic decision support and supply-chain system in hospital services WP503-5: Usability, efficiency and cost-effectiveness of genomic data in the future health care: Sociological reflections WP503-6: Usability, efficiency and cost-effectiveness of genomic data in the future health care: Estimation of cost-effectiveness WP503-7a: A Business Model Perspective to Personalized Diagnostics and Care WP503-7b: Application of standardized impact and cost-benefit assessment tool in public-private partnership 11

12 Genomics in chronic inflammation in Finland and Canada (CINFICA) (WP504) WP managers: Jukka Partanen, SPR Veripalvelu and Päivi Saavalainen, HY WP504-1: Continuation of selected IMO biomarkers and platforms WP504-2: Novel genomic biomarkers WP504-3: Novel protein biomarkers WP504-4: Novel cell therapy 12

13 Goals of the program (1 ½ v) (1 ½ v) (1 v)

14 14

Enablers of Intelligent Monitoring of Health and Well-being Review of the SalWe IMO - Programme

Enablers of Intelligent Monitoring of Health and Well-being Review of the SalWe IMO - Programme Enablers of Intelligent Monitoring of Health and Well-being Review of the SalWe IMO - Programme Jouko Haapalahti Programme Director, SalWe Ltd Managing director, JouZeNet Consulting Ltd Coordinator, Finnish

More information

HealthBIO in Helsinki Region 2008 BioSA Workshops in South Africa, 31.3 2.4.2008

HealthBIO in Helsinki Region 2008 BioSA Workshops in South Africa, 31.3 2.4.2008 HealthBIO in Helsinki Region 2008 BioSA Workshops in South Africa, 31.3 2.4.2008 Riikka Paasikivi Program Director Culminatum Ltd Oy Helsinki, Finland Helsinki Region Over 1.2 million inhabitants (population

More information

Information for patients and the public and patient information about DNA / Biobanking across Europe

Information for patients and the public and patient information about DNA / Biobanking across Europe Information for patients and the public and patient information about DNA / Biobanking across Europe BIOBANKING / DNA BANKING SUMMARY: A biobank is a store of human biological material, used for the purposes

More information

UCLA Asian Liver Program

UCLA Asian Liver Program CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,

More information

Clinical drug trials from a university hospital's point of view. Aki Lindén, CEO, Helsinki University Hospital

Clinical drug trials from a university hospital's point of view. Aki Lindén, CEO, Helsinki University Hospital Clinical drug trials from a university hospital's point of view Aki Lindén, CEO, Helsinki University Hospital National Responsibilities and Special Areas 2014 5 university hospital districts: HUCH - Helsinki

More information

BioSA Workshops in South Africa 1.-2.4.2008. Tero Piispanen, Turku Science Park Ltd

BioSA Workshops in South Africa 1.-2.4.2008. Tero Piispanen, Turku Science Park Ltd BioSA Workshops in South Africa 1.-2.4.2008 Tero Piispanen, Turku Science Park Ltd Part I - Finland FINLAND Finland facts Top Competitiveness and Creativity About 5.3 million inhabitants in 337 000 km2

More information

Personalized medicine in China s healthcare system

Personalized medicine in China s healthcare system Personalized medicine in China s healthcare system Jingmin Kan, Sam Linsen Netherlands office for Science and Technology, Guangzhou and Shanghai, China Content PERSONALIZED MEDICINE 2 FOCUS AT THE INDIVIDUAL

More information

Quality and Clinical Director

Quality and Clinical Director Curriculum Vitae PERSONAL INFORMATION Minna Leppänen WORK EXPERIENCE April 2014 Present Quality and Clinical Director Scaffdex Ltd, (Finland) Responsibility in quality, regulatory and clinical issues concerning

More information

Maritta Perälä-Heape

Maritta Perälä-Heape Maritta Perälä-Heape OULU INNOVATION ALLIANCE (OIA) BRINGS TOGETHER REGIONAL STAKEHOLDERS MODE OF OPERATION Systematic, contract-based RD co-operation between regional players Composing and coordinating

More information

FUTURE HEALTH COOPERATION BETWEEN PUBLIC AND PRIVATE SECTORS IN KUOPIO

FUTURE HEALTH COOPERATION BETWEEN PUBLIC AND PRIVATE SECTORS IN KUOPIO FUTURE HEALTH COOPERATION BETWEEN PUBLIC AND PRIVATE SECTORS IN KUOPIO Anneli Tuomainen, Johanna Jylhä-Ollila Kuopio Innovation Ltd, POB 4000, FI-70601 Kuopio, Finland Context In Finland, cities, companies

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

Advanced Nursing Research in Critical Care

Advanced Nursing Research in Critical Care 12 th Congress of the World Federation of Societies of Intensive and Critical Care Medicine Advanced Nursing Research in Critical Care Yeonsoo Jang RN, PhD. Assistant Professor Yonsei University College

More information

4.11 Healthcare Technology Co-operatives Version 4 (July 2015)

4.11 Healthcare Technology Co-operatives Version 4 (July 2015) HEALTHCARE TECHNOLOGY CO-OPERATIVES Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out

More information

Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis

Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis We are MyCartis Let s make healthcare personal The big revolution in healthcare today is that we are finally realizing

More information

ACRONIM : InNerMeD-I-Network. STARTING DATE: 2013-04-01 DURATION (in months): 30. PRIORITY AREA: Actions under the second objective 'Promote health'

ACRONIM : InNerMeD-I-Network. STARTING DATE: 2013-04-01 DURATION (in months): 30. PRIORITY AREA: Actions under the second objective 'Promote health' IInherriitted NeuRoMettabolliic Diiseases IINFORMATIION NETWORK ACRONIM : InNerMeD-I-Network STARTING DATE: 2013-04-01 DURATION (in months): 30 PRIORITY AREA: Actions under the second objective 'Promote

More information

Centre for Health and Technology. Maritta Perälä-Heape

Centre for Health and Technology. Maritta Perälä-Heape Centre for Health and Technology Maritta Perälä-Heape OULU INNOVATION ALLIANCE (OIA) BRINGS TOGETHER REGIONAL STAKEHOLDERS MODE OF OPERATION Systematic, contract-based co-operation between regional players

More information

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER?

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER? PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER? PCA3 DETECTION TEST FOR PROSTATE CANCER There is a range of methods available to your healthcare professional to verify the

More information

Content. Helsinki, Finland

Content. Helsinki, Finland Content 1. Helsinki, Finland 2. University of Helsinki 3. Meilahti campus 4. 5. Undergraduate Degrees in the Faculty of Medicine 6. Languages of instruction 7. Exchange studies 20/07/11 1 Helsinki, Finland

More information

MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015

MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015 19th of March 2015 MediSapiens Ltd Because data is not knowledge Bio-IT solutions for improving cancer patient care Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2015 MediSapiens Ltd. All

More information

FIMECC Ltd. 15.6.2010

FIMECC Ltd. 15.6.2010 FIMECC Ltd. FIMECC Ltd. is private owned company that coordinates company driven research programs in the field of mechanical engineering and metals The platform that FIMECC implements is a national publicprivate

More information

The Blood Donor BIOBANK

The Blood Donor BIOBANK The Blood Donor BIOBANK the first successful combination of blood donation and biobanking for medical research 1 1 Zoglmeier et al., TRANSFUSION 2011, 51(5): 1121-1122 Dr. Franz Weinauer SWISSTRANSFUSION

More information

Public-Private Partnerships for Bridging the Innovation Gap in Personalized Medicine

Public-Private Partnerships for Bridging the Innovation Gap in Personalized Medicine Public-Private Partnerships for Bridging the Innovation Gap in Personalized Medicine Martin LeBlanc, President and CEO, Caprion The 2014 ISPIM Americas Innovation Forum October 6, 2014 1 CHALLENGES FOR

More information

A leader in the development and application of information technology to prevent and treat disease.

A leader in the development and application of information technology to prevent and treat disease. A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today

More information

Helsinki Business Hub. 23 September 2009, Eero Holstila

Helsinki Business Hub. 23 September 2009, Eero Holstila Helsinki Business Hub 2009 23 September 2009, Eero Holstila testi Strategic location Helsinki Performs 2nd/ 118 European Competitiveness Index 2006-2007 6th/ 131 Global Competitiveness Index 2008-2009

More information

+ REACTIONS. Kantar Health discusses. disease (IBD) market. pharma.

+ REACTIONS. Kantar Health discusses. disease (IBD) market. pharma. REACTIONS the evolving inflammatory bowel disease (IBD) market Kantar Health discusses the increased prevalence of ibd, how it will affect the current and future market, and opportunities for pharma. april

More information

The National Centre for Biomedical Engineering Science

The National Centre for Biomedical Engineering Science The How this Integrated Technology Platform has impacted the development of R&D Clusters in Galway Jacinta Thornton, PhD Executive Manager, NCBES National Centre for Biomedical Engineering g Science Mission

More information

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending... CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and

More information

Anaemia Patient information

Anaemia Patient information Anaemia Patient information What is anaemia? Anaemia is the result of either not having enough red cells to take oxygen around the body, or having faulty red cells that are unable to carry enough oxygen.

More information

Information Technology in Healthcare

Information Technology in Healthcare Project name Seminar Report Information Technology in Healthcare Authors Thirza van den Broek Venla Virkamäki On Tuesday May 19, 2015, the Embassy of the Kingdom of the Netherlands together with Philips

More information

IVD toimialan tuloksia, kokemuksia ja näkymiä. Results, experiences and outlook of the IVD sector

IVD toimialan tuloksia, kokemuksia ja näkymiä. Results, experiences and outlook of the IVD sector 1 IVD toimialan tuloksia, kokemuksia ja näkymiä Results, experiences and outlook of the IVD sector FinnWell Seminar of April 29, 2009 Finlandia talo, Helsinki Jouko Haapalahti,M.D,PhD.(hc), emba Assistant

More information

60 Including some of the most influential public health thought leaders Prominent public health leaders and decision makers.

60 Including some of the most influential public health thought leaders Prominent public health leaders and decision makers. Promote & Showcase Sponsor Network & Connect About the Conference The 2nd Singapore International Public Health Conference and 11th Singapore Public Health and Occupational Medicine Conference 2016(SIPHC

More information

Dr Paul Mundill Innostics Innostics Oy

Dr Paul Mundill Innostics Innostics Oy Dr Paul Mundill Innostics Oy Future Diagnostics Finland Ideas for Query 2009 The aim was to assess the future directions and needs of the Finnish in vitro diagnostics industry and to collect foresights

More information

2019 Healthcare That Works for All

2019 Healthcare That Works for All 2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To

More information

New Opportunities in IMI2. Hugh Laverty ECSEL Consortium Building Event Brussels

New Opportunities in IMI2. Hugh Laverty ECSEL Consortium Building Event Brussels New Opportunities in IMI2 Hugh Laverty 14.04.2015 ECSEL Consortium Building Event Brussels Innovative Medicines Initiative: Joining forces in the healthcare sector The biggest public/private partnership

More information

Toward Acceleration of Open Innovation

Toward Acceleration of Open Innovation Toward Acceleration of Open Innovation ーThe Role of Industrial-Academic- Government-Collaborationー Masafumi Nogimori Representative Director and Chairman Astellas Pharm Inc. International Symposium New

More information

Talent Retention in the Helsinki Region: Overcoming the Language Barrier

Talent Retention in the Helsinki Region: Overcoming the Language Barrier Talent Retention in the Helsinki Region: Overcoming the Language Barrier Fluent Finnish Required For the international talents finding employment in Finland is often hindered by a lack of Finnish language

More information

Nanomedicine in Horizon 2020

Nanomedicine in Horizon 2020 Nanomedicine in Horizon 2020 Heico FRIMA Programme Officer European Commission Directorate-General for Research & Directorate D: Key Enabling Technologies heico.frima@ec.europa.eu ETPN Annual Event 2014

More information

Groundbreaking Collaborative Clinical Trial Launched

Groundbreaking Collaborative Clinical Trial Launched Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)

More information

LIFE SCIENCE GROUP LSG Health is a group effort

LIFE SCIENCE GROUP LSG Health is a group effort LIFE SCIENCE GROUP LSG Health is a group effort BASIC INFORMATION AND COMMUNICATION PLAN + Q&A 1. BASIC INFORMATION Project Life Science Group Stakeholders Advisory group Pharma Health Tech Industry associations,

More information

A New Anti-inflammatory Therapy For COPD

A New Anti-inflammatory Therapy For COPD A New Anti-inflammatory Therapy For COPD A Brief Introduction to COPD Current Treatment of COPD Corticosteroid Resistant Chronic Inflammation Looking For New Anti-inflammatory Therapy Introduction to Moxibustion

More information

ICT in the Health, demographic change and well being challenge

ICT in the Health, demographic change and well being challenge ICT in the Health, demographic change and well being challenge Stephen O Reilly National Delegate & Contact Point for ICT & FET Health Information Day January 16 th 2014 A new approach A new approach.

More information

ITT Advanced Medical Technologies (Ileri Tip Teknolojileri)

ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,

More information

EMA and Progressive Multifocal Leukoencephalopathy.

EMA and Progressive Multifocal Leukoencephalopathy. EMA and Progressive Multifocal Leukoencephalopathy. ENCePP Plenary, London 23 November 2011 Presented by: Henry Fitt Head of Coordination & Networking, Pharmacovigilance & Risk Management An agency of

More information

Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics

Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics Response by the Genetic Interest Group Question 1: Health

More information

The 100,000 Genomes Project The North East and North Cumbria Genomic Medicine Centre

The 100,000 Genomes Project The North East and North Cumbria Genomic Medicine Centre The 100,000 Genomes Project The North East and North Cumbria Genomic Medicine Centre Rare Disease Recruitment Gastroenterological disorders Introduction & Eligibility Pack Invitation Pack Printed: 16/09/2016

More information

David ITIER Coordinator of European Affairs at Institut Pasteur National Contact Point «Health, demographic change and Wellbeing»

David ITIER Coordinator of European Affairs at Institut Pasteur National Contact Point «Health, demographic change and Wellbeing» David ITIER Coordinator of European Affairs at Institut Pasteur National Contact Point «Health, demographic change and Wellbeing» Chisinau, 9th November 2015 1 Key features on Horizon 2020 Chisinau, 9th

More information

Roche Position on Human Stem Cells

Roche Position on Human Stem Cells Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with

More information

How can we generate economic value from personalized medicine and big data analysis?

How can we generate economic value from personalized medicine and big data analysis? Estonian Health Innovation Forum 2015 Focus on Personalised Medicine How can we generate economic value from personalized medicine and big data analysis? Jonathan Knowles October 26, 2015 Tallinn, Viru

More information

MEDIA RELEASE. Embargoed until 10:00 9 th November 2014

MEDIA RELEASE. Embargoed until 10:00 9 th November 2014 MEDIA RELEASE Embargoed until 10:00 9 th November 2014 National Ovarian Cancer Research Strategy Launch For the First Time Critical Pathways Mapped to Better Care and Survival Rates for One of Australia

More information

P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything

P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything Leroy E. Hood Institute for Systems Biology David J. Galas Battelle Memorial Institute Version

More information

Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe

Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe Chair Clinical Affairs Committee, BSR Outline The British Society for Rheumatology Challenges in improving patient outcomes

More information

Health and Social Care Level 3. Unit 6 Sociological perspectives for health and social care

Health and Social Care Level 3. Unit 6 Sociological perspectives for health and social care Unit 6 Sociological perspectives for health and social care Definitions of Health Instructions and answers for Teachers These instructions should accompany the OCR resource Definitions of Health, which

More information

In Vitro Diagnostics

In Vitro Diagnostics REVIEW 316/2015 In Vitro Diagnostics a Finnish Success Story A Review of the Finnish IVD Industry Development and Their Success in the Global Market Dr Paul Mundill Tekes the Finnish Funding Agency for

More information

Tekes research call 2015 for health & wellness themes

Tekes research call 2015 for health & wellness themes Tekes research call 2015 for health & wellness themes Pekka Kahri, Director Information event 10.12.2014 1381236 Agenda and presentation content Background for the call Tekes strategy in health & wellness

More information

Horizon 2020 New Opportunities for Clinical Research in Europe

Horizon 2020 New Opportunities for Clinical Research in Europe Horizon 2020 New Opportunities for Clinical Research in Europe Ruxandra Draghia Akli, MD, PhD Director, Health Research DG Research and Innovation European Commission Electronic Health Records for Clinical

More information

Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care

Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care Services January 2015 1 IPU Submission to the Department

More information

XIV ANNUAL MEETING OF NURSING

XIV ANNUAL MEETING OF NURSING Archive of Oncology 2000;8(Suppl 1):69. SESSION 5 XIV ANNUAL MEETING OF NURSING 69 Archive of Oncology 2000;8(Suppl 1):70. 70 UDC: 616.34-007.272:616-089.8:614.39 I. GAJI M. ULAFI Æ. MIHAJLOVI R. NE I

More information

Our Blood Service ANNUAL REPORT

Our Blood Service ANNUAL REPORT Our Blood Service ANNUAL REPORT 2012 Finnish Red Cross Blood Service Part of the Finnish health care system THE FINNISH Red Cross Blood Service (FRCBS) is a financially and operationally independent unit

More information

JAMK University of Applied Sciences. School of Health and Social Studies

JAMK University of Applied Sciences. School of Health and Social Studies JAMK University of Applied Sciences School of Health and Social Studies We promote competence in health and well-being. Ph.D. Pertti Malkki, Director, JAMK, School of Health and Social Studies 1650 Students

More information

Medical Therapies Limited EGM Presentation

Medical Therapies Limited EGM Presentation Medical Therapies Limited EGM Presentation Maria Halasz Chief Executive Officer 5 May 2009 1 Agenda 1. Company information 2. Recent developments 3. Business strategy 4. Key value inflection points for

More information

BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY

BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY Introduction The BSc in Gastroenterology and Hepatology allows a science-based study of the physiology, cell biology, pathology and pharmacology

More information

KATHLEEN M. THOMSEN MD, MPH, ABIHM Integrative & Holistic Health & Wellness 252 West Delaware Avenue Pennington, NJ

KATHLEEN M. THOMSEN MD, MPH, ABIHM Integrative & Holistic Health & Wellness 252 West Delaware Avenue Pennington, NJ KATHLEEN M. THOMSEN MD, MPH, ABIHM Integrative & Holistic Health & Wellness 252 West Delaware Avenue Pennington, NJ 08534 609-818-9700 Greetings, Thank you for your interest in our holistically oriented

More information

Innovate to accelerate

Innovate to accelerate Innovate to accelerate Turku Science Park - focused business development and a campus area Two universities: University of Turku and Åbo Akademi University Turku University of Applied Sciences, Diaconia

More information

Tero Aittokallio, EMBL Group Leader, Institute for Molecular Medicine Finland (FIMM), University of Helsinki (consortium PI)

Tero Aittokallio, EMBL Group Leader, Institute for Molecular Medicine Finland (FIMM), University of Helsinki (consortium PI) CONTROL - Synthetic controllability of biological networks through understanding and engineering their control elements Tero Aittokallio, EMBL Group Leader, Institute for Molecular Medicine Finland (FIMM),

More information

FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.

FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease. HIV & AIDS What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease. What does HIV stand for? Human Immunodeficiency Virus Where did HIV

More information

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing These Are Hopeful Times for Lung Cancer Survivors When people first learn they have cancer, they are often afraid. But

More information

Genetic diagnostics the gateway to personalized medicine

Genetic diagnostics the gateway to personalized medicine Micronova 20.11.2012 Genetic diagnostics the gateway to personalized medicine Kristiina Assoc. professor, Director of Genetic Department HUSLAB, Helsinki University Central Hospital The Human Genome Packed

More information

Genetic Tests for Health Purposes

Genetic Tests for Health Purposes Genetic Tests for Health Purposes Genetic Tests for Health Purposes We have all inherited a unique combination of genes from our parents. This original constitution and the influence of various environmental

More information

THE LINCOLN INSTITUTE OF HEALTH

THE LINCOLN INSTITUTE OF HEALTH THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges

More information

Selective IgA deficiency (slgad) hello@piduk.org 0800 987 8986 www.piduk.org

Selective IgA deficiency (slgad) hello@piduk.org 0800 987 8986 www.piduk.org Selective IgA deficiency (slgad) hello@piduk.org 0800 987 8986 www.piduk.org About this booklet This booklet provides information on selective IgA deficiency (sigad). It has been produced by the PID UK

More information

PHARMACEUTICAL BIGDATA ANALYTICS

PHARMACEUTICAL BIGDATA ANALYTICS PHARMACEUTICAL BIGDATA ANALYTICS ANDINSIGHTS December 2013 Strategic Research Insights, Inc. 2013 Sources of Big Data in rpharmaceutical and Healthcare Industry Challenges with Big Data in Pharma Oncology

More information

Health Data Governance: Privacy, Monitoring and Research - Policy Brief

Health Data Governance: Privacy, Monitoring and Research - Policy Brief Health Data Governance: Privacy, Monitoring and Research - Policy Brief October 2015 www.oecd.org/health Highlights All countries can improve their health information systems and make better use of data

More information

Pathology Department

Pathology Department Banha University Faculty of Medicine Pathology Department Third Year Student's Guide and Activity Book Student's Name: Student's Number: Group: 00-0 - 0 - Course Specifications University : Benha Faculty

More information

WHO strategy for prevention and control of chronic respiratory diseases

WHO strategy for prevention and control of chronic respiratory diseases WHO/MNC/CRA/02.1 Original: English WHO strategy for prevention and control of chronic respiratory diseases World Health Organization Management of Noncommunicable Diseases Department Chronic Respiratory

More information

INNOVATIONS. Tero Välimaa Ph.D., M.Sc. (Eng) FinnMedi BioneXt Tampere

INNOVATIONS. Tero Välimaa Ph.D., M.Sc. (Eng) FinnMedi BioneXt Tampere INNOVATIONS FOR WELLBEING Tero Välimaa Ph.D., M.Sc. (Eng) FinnMedi BioneXt Tampere 1 BioneXt BioneXt Tampere was a development and investment programme focusing on top- level research, product development,

More information

How does genetic testing work?

How does genetic testing work? How does genetic testing work? What is a genetic test? A genetic test looks at to find changes (variants) that cause disease or put you at greater risk to develop disease. DNA is the code our bodies use

More information

Increase Hepatitis C Virus Screening and Treatment

Increase Hepatitis C Virus Screening and Treatment 18 Increase Hepatitis C Virus Screening and Treatment Situation The number of deaths from liver cancer in Japan has been rising rapidly since 1975, and now stands at more than 30,000 per year. About 80

More information

2003 FIRST MINISTERS ACCORD

2003 FIRST MINISTERS ACCORD 2003 FIRST MINISTERS ACCORD ON HEALTH CARE RENEWAL 1 In September 2000, First Ministers agreed on a vision, principles and action plan for health system renewal. Building from this agreement, all governments

More information

FEDERAL PAIN PORTFOLIO PREVIEW

FEDERAL PAIN PORTFOLIO PREVIEW FEDERAL PAIN PORTFOLIO PREVIEW Federal Agencies: AHRQ, CDC, DoD, FDA, NIH, VA Interagency Pain Research Coordinating Committee March 27, 2012 IPRCC Charge I. Develop a summary of advances in pain care

More information

Corportate Wellness Programs

Corportate Wellness Programs Corportate Wellness Programs EAST WEST HEALTH CORPORATE WELLNESS PROGRAMS WE SAVE LIVES BY MOTIVATING INDIVIDUALS AND ORGANIZATIONS TO GET AND STAY HEALTHY. What s going on with the health of our country?

More information

Nuevas tecnologías basadas en biomarcadores para oncología

Nuevas tecnologías basadas en biomarcadores para oncología Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS

More information

Healthcare Innovation: Industry Challenges Being Addressed by Global One Hitachi

Healthcare Innovation: Industry Challenges Being Addressed by Global One Hitachi 636 Hitachi Review Vol. 64 (2016), No. 10 Overview Healthcare Innovation: Industry Challenges Being Addressed by Global One Hitachi Harry Reddy, MS, MEng., MBA, Ph.D. (cont.) Tomoyoshi Takeo CHANGES SOUGHT

More information

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from

More information

Understanding specialty drugs

Understanding specialty drugs Group Benefits Understanding specialty drugs What your pharmaceutical benefits plan may look like over the next decade Between 2011 and 2014, the percentage of total drug spend represented by specialty

More information

DNA Sequencing and Personalised Medicine

DNA Sequencing and Personalised Medicine DNA Sequencing and Personalised Medicine Mick Watson Director of ARK-Genomics The Roslin Institute PERSONALISED MEDICINE What is personalised medicine? Personalized Medicine refers to the tailoring of

More information

VTT as an Innovation Partner. Petri Kalliokoski EVP, Strategy and Business Development

VTT as an Innovation Partner. Petri Kalliokoski EVP, Strategy and Business Development VTT as an Innovation Partner Petri Kalliokoski EVP, Strategy and Business Development 2 Agenda 18.1.2012 9:00 Welcome, VTT as an Innovation Partner/Petri Kalliokoski, Executive Vice President 9:30 Experiences

More information

Kidney Health: Secrets we all need to be talking about

Kidney Health: Secrets we all need to be talking about Kidney Health: Secrets we all need to be talking about Tipu S. Puri M.D., Ph.D. University of Chicago Medicine Chair, NKFI Professional Advisory Board A patient Michael o 36 year old male o African-american

More information

Guidelines for health professionals about DNA / Biobanking in Europe

Guidelines for health professionals about DNA / Biobanking in Europe Guidelines for health professionals about DNA / Biobanking in Europe BIOBANKING SUMMARY A "biobank" is a: "service unit, non-profit organization for the collection and preservation of biological material

More information

Breast cancer and genetics

Breast cancer and genetics Breast cancer and genetics Cancer and genes Our bodies are made up of millions of cells. Each cell contains a complete set of genes. We have thousands of genes. We each inherit two copies of most genes,

More information

QUESTIONS FOR The Commonwealth Medical College

QUESTIONS FOR The Commonwealth Medical College Page 1 QUESTIONS FOR The Commonwealth Medical College PROCESS OF CURRICULUM REDESIGN Why did you redesign your curriculum? What were your goals? What was the timeframe? What lessons were learned while

More information

JA-CHRODIS at a glance

JA-CHRODIS at a glance Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle. JA-CHRODIS at a glance This document arises from the EU CHRODIS Joint Action which has received funding from the European

More information

Regulatory Issues in Genetic Testing and Targeted Drug Development

Regulatory Issues in Genetic Testing and Targeted Drug Development Regulatory Issues in Genetic Testing and Targeted Drug Development Janet Woodcock, M.D. Deputy Commissioner for Operations Food and Drug Administration October 12, 2006 Genetic and Genomic Tests are Types

More information

BIOSCIENCES COURSE TITLE AWARD

BIOSCIENCES COURSE TITLE AWARD COURSE TITLE AWARD BIOSCIENCES As a Biosciences undergraduate student at the University of Westminster, you will benefit from some of the best teaching and facilities available. Our courses combine lecture,

More information

CMI platform on Rheumatoid Arthritis June 18, 2013

CMI platform on Rheumatoid Arthritis June 18, 2013 platform on Rheumatoid Arthritis June 18, 2013 Veerle Somers, Piet Stinissen, Piet Geusens Rene Westhovens, Patrick Verschueren, Rik Lories Dirk Elewaut, Filip Van den Bosch Luc De Clerck UHasselt KULeuven/UZLeuven

More information

Medicare Coverage of Genomic Testing

Medicare Coverage of Genomic Testing Medicare Coverage of Genomic Testing Louis B. Jacques, MD Director, DID/CAG/OCSQ With acknowledgements to Jeff Roche, MD Social Security Act 1862(a)(1)(A) Notwithstanding any other provision of this title,

More information

Building a Collaborative Informatics Platform for Translational Research: Prof. Yike Guo Department of Computing Imperial College London

Building a Collaborative Informatics Platform for Translational Research: Prof. Yike Guo Department of Computing Imperial College London Building a Collaborative Informatics Platform for Translational Research: An IMI Project Experience Prof. Yike Guo Department of Computing Imperial College London Living in the Era of BIG Big Data : Massive

More information

Business from Research Innovation at VTT

Business from Research Innovation at VTT Business from Research Innovation at VTT Vesi-ohjelman vuosiseminaari, 22.11.2011 Timo Pulli, Business Development Manager timo.pulli@vtt.fi, +358 40 720 7152 VTT Technical Research Centre of Finland 2

More information

From the Dean. Tuija Pulkkinen Dean

From the Dean. Tuija Pulkkinen Dean Signal of quality From the Dean At the School of Electrical Engineering, science and engineering meet society. Our portfolio covers fields from natural sciences to engineering and information sciences.

More information

Australian Federation of AIDS Organisations (AFAO) Primary Health Care Reform

Australian Federation of AIDS Organisations (AFAO) Primary Health Care Reform Australian Federation of AIDS Organisations (AFAO) Primary Health Care Reform 27 February 2009 1 Introduction The Australian Federation of AIDS Organisations (AFAO) is the peak body for Australia s community

More information

MASTER S DEGREE PROGRAMME IN BIOINFORMATICS

MASTER S DEGREE PROGRAMME IN BIOINFORMATICS 07.07.08.mat.luonnont.sivut 08 7.7.2008 13:44 Sivu 183 MASTER S DEGREE PROGRAMME IN BIOINFORMATICS Department of Computer Science Department of Mathematics and Statistics Exactum (Kumpula Campus) PO Box

More information